Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CTSS | P25774 | 3/20 | 0.39 |
| ▸ | CTSK | P43235 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA7 | P43166 | 2/20 | 0.37 |
| ▸ | BTK | Q06187 | 1/20 | 0.37 |
| ▸ | CTSL | P07711 | 1/20 | 0.37 |
| ▸ | CTSB | P07858 | 1/20 | 0.37 |
| ▸ | AKT1 | P31749 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.35 |
| ▸ | APLNR | P35414 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL76832 | 0.81 | KDM4C (0.41) | MEN1GAAKMT2ACTSSCTSK | |
| SCHEMBL25229366 | 0.81 | MEN1 (0.44) | MEN1GAAKMT2ACTSSCTSK | |
| SCHEMBL21834933 | 0.79 | KDM4C (0.39) | MEN1GAAKMT2ACTSSCTSK | |
| SCHEMBL8144616 | 0.79 | MEN1 (0.39) | MEN1GAAKMT2ACTSSCTSK | |
| SCHEMBL16296168 | 0.79 | KDM4C (0.39) | MEN1GAAKMT2ACTSSCTSK | |
| SCHEMBL25811478 | 0.79 | CTSK (0.41) | MEN1GAAKMT2ACTSSCTSK | |
| SCHEMBL22045503 | 0.77 | MEN1 (0.38) | MEN1GAAKMT2ACTSSCTSK | |
| SCHEMBL13744302 | 0.77 | MEN1 (0.38) | MEN1GAAKMT2ACTSSCTSK | |
| SCHEMBL22577405 | 0.77 | MEN1 (0.38) | MEN1GAAKMT2ACTSSCTSK | |
| SCHEMBL1100241 | 0.77 | MEN1 (0.38) | MEN1GAAKMT2ACTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9386938-B2 | Methods for collagen imaging | Collagen Medical, LLC (US) | 2016-07-12 | — | — | US | disclosed |
| US-20120114557-A1 | Methods for Collagen Imaging | Collagen Medical, LLC (US) | 2012-05-10 | — | — | US | disclosed |
| US-8034898-B2 | Methods of collagen imaging | Collagen Medical, LLC (US) | 2011-10-11 | — | — | US | disclosed |
| US-20080058636-A1 | METHODS OF MYOCARDIAL IMAGING | EPIX PHARMACEUTICALS, INC. | 2008-03-06 | — | — | US | disclosed |
| US-20080044360-A1 | METHODS OF COLLAGEN IMAGING | EPIX PHARMACEUTICALS, INC. | 2008-02-21 | — | — | US | disclosed |
| US-20070293656-A1 | COLLAGEN BINDING PEPTIDES | EPIX PHARMACEUTICALS, INC. | 2007-12-20 | — | — | US | disclosed |
| WO-2007084264-A2 | METHODS FOR MYOCARDIAL IMAGING | EPIX PHARMACEUTICALS, INC. (US) | 2007-07-26 | — | — | WO | disclosed |
| US-6436980-B1 | TRANSPORT PROTEIN SUPPRESSORS; MICROBIOCIDES | ESSENTIAL THERAPEUTICS, INC. | 2002-08-20 | — | — | US | disclosed |
| US-6204279-B1 | SECONDARY AMIDE CONTAINING BENZOXAZOLE DERIVATIVES | MICROCIDE PHARMACEUTICALS, INC. | 2001-03-20 | — | — | US | disclosed |
| WO-1999037667-A1 | EFFLUX PUMP INHIBITORS | MICROCIDE PHARMACEUTICALS, INC. (US) | 1999-07-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120114557-A1 | Methods for Collagen Imaging | COL14A1, COL2A1, COL1A1 | MEN1 1017/4885GAA 3704/4885KMT2A 4757/4885 |
| US-20080058636-A1 | METHODS OF MYOCARDIAL IMAGING | FABP3, TNNI3, TNNT2 | MEN1 2037/4885GAA 3486/4885KMT2A 4870/4885 |
| US-20080044360-A1 | METHODS OF COLLAGEN IMAGING | COL14A1, COL2A1, COL1A1 | MEN1 822/4885GAA 3768/4885KMT2A 4824/4885 |
| US-20070293656-A1 | COLLAGEN BINDING PEPTIDES | COL14A1, COL2A1, COL1A1 | MEN1 3694/4885GAA 2574/4885KMT2A 4714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.